Design and Rationale for comParison Between ticagreLor and clopidogrEl on mIcrocirculation in Patients with Acute cOronary Syndrome Undergoing Percutaneous Coronary Intervention (PLEIO) Trial

It has been previously demonstrated that ticagrelor can reduce mortality compared to clopidogrel in acute coronary syndrome (ACS) patients. However, the mechanism for this mortality reduction remains uncertain. The objective of the present study is to assess the impact of chronic ticagrelor treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Kyungil, Cho, Young-Rak, Park, Jong-Sung, Park, Tae-Ho, Kim, Moo-Hyun, Kim, Young-Dae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Methods Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846973/
https://www.ncbi.nlm.nih.gov/pubmed/29344840
http://dx.doi.org/10.1007/s12265-017-9783-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846973/
https://www.ncbi.nlm.nih.gov/pubmed/29344840
http://dx.doi.org/10.1007/s12265-017-9783-8

Ejemplares similares